A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis

Adeliane Castro da Costa; Abadio de Oliveira Costa-Júnior; Fábio Muniz de Oliveira; Sarah Veloso Nogueira; Joseane Damaceno Rosa; Danilo Pires Resende; André Kipnis; Ana Paula Junqueira-Kipnis

doi:10.1371/journal.pone.0112848

Loading metrics

Open Access

Peer-reviewed

Research Article

A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis

Adeliane Castro da Costa,

Affiliation Laboratório de Imunopatologia das Doenças Infecciosas, Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Goiás, Brazil
⨯
Abadio de Oliveira Costa-Júnior,

Affiliation Laboratório de Imunopatologia das Doenças Infecciosas, Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Goiás, Brazil
⨯
Fábio Muniz de Oliveira,

Affiliation Laboratório de Bacteriologia Molecular, Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Goiás, Brazil
⨯
Sarah Veloso Nogueira,

Affiliation Laboratório de Imunopatologia das Doenças Infecciosas, Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Goiás, Brazil
⨯
Joseane Damaceno Rosa,

Affiliation Laboratório de Imunopatologia das Doenças Infecciosas, Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Goiás, Brazil
⨯
Danilo Pires Resende,

Affiliation Laboratório de Imunopatologia das Doenças Infecciosas, Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Goiás, Brazil
⨯
André Kipnis,

Affiliation Laboratório de Bacteriologia Molecular, Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Goiás, Brazil
⨯
Ana Paula Junqueira-Kipnis

* E-mail: apkipnis@gmail.com

Affiliation Laboratório de Imunopatologia das Doenças Infecciosas, Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Goiás, Brazil
⨯

A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis

Adeliane Castro da Costa,
Abadio de Oliveira Costa-Júnior,
Fábio Muniz de Oliveira,
Sarah Veloso Nogueira,
Joseane Damaceno Rosa,
Danilo Pires Resende,
André Kipnis,
Ana Paula Junqueira-Kipnis

Published: November 14, 2014
https://doi.org/10.1371/journal.pone.0112848

Reader Comments (1)

Post a new comment on this article

0 Responses

15 Nov 2014
10:32 GMT
Most Recent

The Figure 8 was published incorrect. Posted by anakipnis on 15 Nov 2014 at 10:32 GMT

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Mycobacterium tuberculosis
Is the Subject Area "Mycobacterium tuberculosis" applicable to this article?

Thanks for your feedback.
Recombinant vaccines
Is the Subject Area "Recombinant vaccines" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.
Macrophages
Is the Subject Area "Macrophages" applicable to this article?

Thanks for your feedback.
Vaccination and immunization
Is the Subject Area "Vaccination and immunization" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Tuberculosis
Is the Subject Area "Tuberculosis" applicable to this article?

Thanks for your feedback.